Malignant peritoneal mesothelioma (MPM) is a rare and aggressive cancer associated with a poor prognosis. Its presentation mimics a spectrum of conditions, making diagnosis and management particularly ...

Prasad Adusumilli and colleagues have shown that CAR T cells that start to lose power can be revived by immunotherapy drugs given several weeks later. Mesothelioma is a rare cancer that affects the ...

Dr. Hedy Kindler joins us on the podcast to discuss the latest update to the treatment of pleural mesothelioma guideline. She discusses the latest changes to the updated recommendations across topics ...

Patients with mesothelioma may be getting a new second-line treatment, thanks to results from a recent immunotherapy trial. For patients with malignant pleural mesothelioma — which makes up about 90 ...

Mesothelioma, a type of lung cancer highly associated with asbestos exposure, has a five-year survival rate of only 10%. Following the CheckMate 743 trial, the dual immune checkpoint inhibitor (ICI) ...

“ADDRI’s leadership in asbestos-related disease makes Australia a compelling setting for a TT-4 investigator-initiated trial,” said Peter Molloy, Chief Executive Officer, Cyncado Therapeutics. “We are ...

Tamron Little, diagnosed with peritoneal mesothelioma during pregnancy, underwent HIPEC surgery and has survived 18 years beyond her initial prognosis. She emphasizes the importance of mental health ...

Mesothelioma is a highly fatal disease with a survival rate of under 10% at five years. New advances with immunotherapy have improved survival, but only 23% of patients are alive at three years when ...

Start-up US biotech company tackling rare diseases presents three case studies in France LILLE, France--(BUSINESS WIRE)--RS Oncology is bringing exciting new science to patients who will have the best ...

Warren Zevon, a brilliant, underappreciated songwriter who was known for his dark humor, will soon be inducted into the Rock ...

For over three decades, the Halpern Law Firm has been committed to representing individuals and families impacted by asbestos exposure and mesothelioma. Sponsoring iMig 2025 reflects the firm's ...